The combined treatment with ketoconazole and ATRA for bladder cancer after transurethral resection of bladder tumor (TURBT) significantly improved the survival and reduced recurrence through decreasing levels of vascular endothelial growth factor (VEGF) and transforming growth factor-α (TGF-β) [46]. Here, TGFB1 is linked to urinary bladder cancer.